What screening test should be performed on all sexually active women under 24 years of age?

Chlamydia and gonorrhoeae screening is recommended for all sexually active women under 24 years of age due to the increased risk of sexually transmitted infections (STIs) within this age group. These infections can often be asymptomatic, leading to complications such as pelvic inflammatory disease, infertility, and further transmission to others if not identified and treated early.

The U.S. Preventive Services Task Force and the Centers for Disease Control and Prevention both endorse routine screening for Chlamydia and gonorrhea for sexually active young women. This proactive measure aims to detect these infections early, ensuring appropriate management and reducing the risk of long-term health issues associated with untreated STIs.

While Pap smears are important for cervical cancer screening, they are not recommended annually for young women who are under 21 or have had no abnormal findings previously. HIV testing is also vital, but it is typically not standardized for all sexually active individuals in this age group unless specific risk factors are present. Syphilis testing is more targeted, focusing on those with specific risks or symptoms rather than a blanket screening approach for all sexually active young women. Therefore, the screening for Chlamydia and gonorrhea specifically addresses the common and concerning STIs affecting young women and aims for